Evidence map›Paper›PMID 34727633›Full record

ArticleAnimal bioscience2022

Curcumin represses lipid accumulation through inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes.

Shifeng Pan, Yongfang Chen, Lin Zhang, Zhuang Liu, Xingyu Xu, Hua Xing

Open access · goldAbstract read
In one paragraph

Article in Animal bioscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Shifeng PanCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Yongfang ChenCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Lin ZhangCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Zhuang LiuCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Xingyu XuCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Hua XingCollege of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, 225009, China.
Yangzhou University · CNWashington State University · US

Funding

China Postdoctoral Science Foundation Funded Project 2015M581872National Natural Science Foundation of China 31501923National Natural Science Foundation of China 32072809Natural Science Foundation of Jiangsu Province BK20150443Natural Science Foundation of Jiangsu Province BK20211119Postdoctoral Science Foundation Funded Project of Jiangsu Province 1501073APostgraduate Research & Practice Innovation Program of Jiangsu Province KYCX21_3275Priority Academic Program Development of Jiangsu Higher Education InstitutionsYangzhou University 137080146Yangzhou University 2019CXJ140
6 · The paper itself

Abstract

objectiveExcessive lipid accumulation in adipocytes results in prevalence of obesity and metabolic syndrome. Curcumin (CUR), a naturally phenolic active ingredient, has been shown to have lipid-lowering effects. However, its underlying mechanisms have remained largely unknown. Therefore, the study aims to determine the effect of CUR on cellular lipid accumulation in porcine subcutaneous preadipocytes (PSPA) and to clarify novel mechanisms.

methodsThe PSPA were cultured and treated with or without CUR. Both cell counting Kit-8 and lactate dehydrogenase release assays were used to examine cytotoxicity. Intracellular lipid contents were measured by oil-red-o staining extraction and triglyceride quantification. Apoptosis was determined by flow cytometry and the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-nick end labelling assay. Adipogenic and apoptosis genes were analyzed by quantitative polymerase chain reaction and Western blot.

resultsThe CUR dose-dependently reduced the proliferation and lipid accumulation of PSPA. Noncytotoxic doses of CUR (10 to 20 μM) significantly inhibited extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation and expression of adipogenic genes peroxisome proliferation-activity receptor-γ (PPAR-γ), CCAAT/enhancer binding protein-α, sterol regulatory element-binding protein-1c, adipocyte protein-2, glucose transporter-4 as well as key lipogenic enzymes fatty acid synthase and acetyl-CoA carboxylase, while ERK1/2 activation significantly reversed CUR-reduced lipid accumulation by increasing PPAR-γ. Furthermore, compared with differentiation induced media treated cells, higher dose of CUR (30 μM) significantly decreased the expression of AKT and B-cell lymphoma-2 (BCL2), while increased the expression of BCL-2-associated X (BAX) and the BAX/BCL-2 expression ratio, suggesting triggered apoptosis by inactivating AKT and increasing BAX/BCL-2 ratio and Caspase-3 expression. Moreover, AKT activation significantly rescued CUR inhibiting lipid accumulation via repressing apoptosis.

conclusionThese results demonstrate that CUR is capable of suppressing differentiation by inhibiting ERK1/2-PPAR-γ signaling pathway and triggering apoptosis via decreasing AKT and subsequently increasing BAX/BCL-2 ratio and Caspase-3, suggesting that CUR provides an important method for the reduction of porcine body fat, as well as the prevention and treatment of human obesity.

Indexed as

Adipogenic DifferentiationAKT/BCL-2/BAX Signaling PathwayApoptosisCurcuminERK1/2-PPAR-γ Signaling PathwayPorcine Subcutaneous Preadipocytes

Identifiers

PMID34727633
PMCPMC9065776
OpenAlexW3210624657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.